NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Appropriations History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Appropriations | ₹409 Cr | ₹378 Cr | ₹2,586,009 Cr | ₹14 Cr | ₹14 Cr |
What is the latest Appropriations of NATH BIOGENES (INDIA) ?
Year | Appropriations |
---|---|
Mar2024 | ₹409 Cr |
Mar2023 | ₹378 Cr |
Mar2022 | ₹2,586,009 Cr |
Mar2013 | ₹14 Cr |
Mar2012 | ₹14 Cr |
How is Appropriations of NATH BIOGENES (INDIA) Trending?
Years | Appropriations | % Change | |
---|---|---|---|
Mar2024 | ₹409 Cr | 8.26 | |
Mar2023 | ₹378 Cr | -99.99 | |
Mar2022 | ₹2,586,009 Cr | 18,322,195.45 | |
Mar2013 | ₹14 Cr | 0.00 | |
Mar2012 | ₹14 Cr | - |
Compare Appropriations of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹375.6 Cr | -1.5% | 3.1% | 0.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,151.0 Cr | -4.3% | -4.8% | 17.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,473.6 Cr | -4.4% | -9.7% | 36.7% | Stock Analytics | |
VENKYS (INDIA) | ₹2,261.5 Cr | -1.7% | -0.5% | -13.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,377.6 Cr | -4.3% | -6.5% | -30.7% | Stock Analytics | |
INDO US BIOTECH | ₹305.8 Cr | -3.6% | 3.7% | -19.6% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -1.5% |
3.1% |
0.7% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses